NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/27/2023
Back to search
Official data from USPTO
BIOINVENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOINVENT
ST13
US500000076019918Class
1, 5, 9, 40, 42
Filing
76019918
Registration
2645062
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
10/27/2023
Trademark type
Word
Nice classes
1, 5, 9, 40, 42
Filing date
04/06/2000
Registration date
11/05/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/27/2023
Last transaction
10/27/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
1
Owner type
03
Owner location
Lund, SE
Examiner
CLARK, GLENN
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
BioInvent International AB
BioInvent International AB
Representatives
Nancy DiConza FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
proteins for scientific and research use; chemical preparations for use in protein analysis; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; proteins for immunoassay for detection of cancerautoimmune diseaseinfectioncardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory disease; and for toxicological studies for scientific use; proteins for biotechnological purposeschromatography; binding proteins and immunoassay reagents contained in boxestrays or other receptaclessold together as a unitfor scientific use
Class 5
diagnostic proteins for clinical or medical laboratory analysis; proteins for therapeutic use for treating cancerautoimmune diseaseinfectioncardiovascular diseaseliver dysfunctionkidney dysfunctiontoxicological conditions and inflammatory disease; biopharmaceuticals for use in cancerautoimmune diseaseinfectioncardiovascular diseaseliver dysfunctionkidney dysfunctioninflammatory disease; and toxicological conditions; laboratory testing kits for clinical or medical purposes comprising a boxtray or other receptacle holding vials containing binding proteins and immunoassays reagentssold together as a unit
Class 9
laboratory testing kits for research purposes comprising a boxtray or other receptacle holding vials containing binding proteins and immunoassay reagentssold together as a unit
Class 40
Contract manufacturing of antibodies for third parties
Class 42
Scientific research and pharmaceutical drug development servicesfor others
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/27/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/27/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/27/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/02/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/05/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/12/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/12/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/12/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/12/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
04/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2017
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/26/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/26/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/26/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/26/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
01/10/2013
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/12/2009
PLGL
ASSIGNED TO PARALEGAL
05/01/2009
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
04/29/2009
E815
TEAS SECTION 8 & 15 RECEIVED
04/29/2009
CFIT
CASE FILE IN TICRS
12/18/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2002
PUBO
PUBLISHED FOR OPPOSITION
08/13/2002
NPUB
NOTICE OF PUBLICATION
07/24/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2002
DOCK
ASSIGNED TO EXAMINER
05/13/2002
DOCK
ASSIGNED TO EXAMINER
04/23/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2001
CNFR
FINAL REFUSAL MAILED
12/18/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2001
CNRT
NON-FINAL ACTION MAILED
09/13/2000
DOCK
ASSIGNED TO EXAMINER
09/11/2000
Continuous trademark protection
Get notified about every new filing that threatens BIOINVENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.